Lv4
546 积分 2020-06-17 加入
磷酸化表皮生长因子受体与鼻咽癌患者预后关系的研究
23天前
已完结
2022年中国恶性肿瘤流行情况分析
24天前
已完结
Cancer incidence and mortality in China, 2022
24天前
已完结
[Consensus on the detection of microsatellite instability in colorectal cancer and other related solid tumors in China]
1个月前
已完结
Comment on “Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM Database”
1个月前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
1个月前
已完结
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
2个月前
已完结
Anticancer Effect of Active Component of Astragalus Membranaceus Combined with Olaparib on Ovarian Cancer Predicted by Network-Based Pharmacology
2个月前
已完结
PARP抑制剂不良反应管理的中国专家共识(2021年版)
2个月前
已完结
Targeting Protein Kinase, Membrane-Associated Tyrosine/Threonine 1 (PKMYT1) for Precision Cancer Therapy: From Discovery to Clinical Trial
3个月前
已完结
皖公网安备34019202002308
